{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:30:56Z","timestamp":1788827456850,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010571","name":"Bundesministerium f\u00fcr Bildung und Forschung Dienststelle Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcf.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T02:45:14Z","timestamp":1705113914000},"page":"234-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Elexacaftor\/tezacaftor\/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor\/ivacaftor"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-1269","authenticated-orcid":false,"given":"Lena","family":"Wucherpfennig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna K.Z.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Wuennemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-2601","authenticated-orcid":false,"given":"Ingo","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-8315","authenticated-orcid":false,"given":"Mirjam","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1666-8924","authenticated-orcid":false,"given":"Simon Y.","family":"Graeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5359-1258","authenticated-orcid":false,"given":"Jaehi","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsattar","family":"Alrajab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Kauczor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-2199","authenticated-orcid":false,"given":"Marcus A.","family":"Mall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3941-8944","authenticated-orcid":false,"given":"Olaf","family":"Sommerburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6962-037X","authenticated-orcid":false,"given":"Mark O.","family":"Wielp\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.01.004_bib0001","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/thx.2008.104711","article-title":"Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis","volume":"64","author":"Mainz","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.01.004_bib0002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2013.01.002","article-title":"Importance of bacteriology in upper airways of patients with cystic fibrosis","volume":"12","author":"Berkhout","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.004_bib0003","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1513\/AnnalsATS.201910-777OC","article-title":"Magnetic resonance imaging detects chronic rhinosinusitis in infants and preschool children with cystic fibrosis","volume":"17","author":"Sommerburg","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.01.004_bib0004","series-title":"Ann Am Thorac Soc","article-title":"Longitudinal mri detects onset and progression of chronic rhinosinusitis from infancy to school age in cystic fibrosis","author":"Wucherpfennig","year":"2022"},{"key":"10.1016\/j.jcf.2024.01.004_bib0005","first-page":"10","article-title":"Increased inflammatory markers detected in nasal lavage correlate with paranasal sinus abnormalities at mri in adolescent patients with cystic fibrosis","author":"Chung","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jcf.2024.01.004_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.03.011","article-title":"Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis","author":"Wucherpfennig","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.004_bib0007","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0008","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1164\/rccm.201910-1943SO","article-title":"Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications","volume":"201","author":"Mall","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642180","article-title":"Ivacaftor reduces inflammatory mediators in upper airway lining fluid from cystic fibrosis patients with a G551D Mutation: serial non-invasive home-based collection of upper airway lining fluid","volume":"12","author":"Mainz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2024.01.004_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1161891","article-title":"Long-term effects of lumacaftor\/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging","volume":"14","author":"Wucherpfennig","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2024.01.004_bib0011","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2022.03.002","article-title":"Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis","volume":"21","author":"Stapleton","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1007\/s00405-023-07859-4","article-title":"Effects of CFTR-modulator triple therapy on sinunasal symptoms in children and adults with cystic fibrosis","author":"Bode","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jcf.2024.01.004_bib0013","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1053\/j.gastro.2004.07.006","article-title":"CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis","volume":"127","author":"Hirtz","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2024.01.004_bib0014","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of Elexacaftor\/Tezacaftor\/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcf.2015.07.003","article-title":"Optical coherence tomography detects structural abnormalities of the nasal mucosa in patients with cystic fibrosis","volume":"15","author":"Oltmanns","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.004_bib0016","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1164\/rccm.201309-1659OC","article-title":"Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease","volume":"189","author":"Wielp\u00fctz","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0017","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1164\/rccm.201807-1203OC","article-title":"Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study","volume":"199","author":"Stahl","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-5876(96)01458-9","article-title":"The paranasal sinuses in CT-imaging: development from birth to age 25","volume":"39","author":"Spaeth","year":"1997","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jcf.2024.01.004_bib0019","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2500\/105065897781446676","article-title":"Paranasal sinus development in chronic sinusitis, cystic fibrosis, and normal comparison population: a computerized tomography correlation study","volume":"11","author":"Kim","year":"1997","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jcf.2024.01.004_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00005537-200302000-00002","article-title":"Paranasal sinus development: a radiographic study","volume":"113","author":"Shah","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcf.2024.01.004_bib0021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0091-6749(92)90184-4","article-title":"Complications of sinusitis","volume":"90","author":"Wagenmann","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcf.2024.01.004_bib0022","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/0194599817717674","article-title":"Endoscopic management of paranasal sinus mucoceles: meta-analysis of visual outcomes","volume":"157","author":"Zukin","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jcf.2024.01.004_bib0023","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0024","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.201710-1983OC","article-title":"Effects of Lumacaftor-Ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in Phe508del homozygous patients with cystic fibrosis","volume":"197","author":"Graeber","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0026","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2024.01.004_bib0027","article-title":"Clinical effectiveness of elexacaftor\/tezacftor\/ivacaftor in people with cystic fibrosis","author":"Nichols","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.004_bib0028","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1513\/AnnalsATS.202008-1054OC","article-title":"Effects of lumacaftor-ivacaftor on lung clearance index, magnetic resonance imaging, and airway microbiome in Phe508del homozygous patients with cystic fibrosis","volume":"18","author":"Graeber","year":"2021","journal-title":"Ann Am Thorac Soc"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:23:43Z","timestamp":1772353423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1569199324000043"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.01.004","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elexacaftor\/tezacaftor\/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor\/ivacaftor","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}